SciClone Pharmaceuticals’ HK$780 Million Voluntary Share Buy-Back Offer

Pietro Martinoia
Tagged:

Kirkland & Ellis advised SciClone Pharmaceuticals on the offer.SciClone Pharmaceuticals (Holdings) Limited (HKSE: 6600) announced its HK$780 million voluntary conditional cash offer to buy-back up to 77,534,791…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now